Učitavanje...

Prostate Cancer Immunotherapy: The Path Forward

PURPOSE OF THIS REVIEW: To provide an overview of current strategies being investigated in the development of immunotherapy in prostate cancer. RECENT FINDINGS: Development of immunotherapy in prostate cancer actually began in 2010 with FDA approval of sipuleucel-T. Given that immune checkpoint inhi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Curr Opin Support Palliat Care
Glavni autori: Madan, Ravi A., Gulley, James L.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258656/
https://ncbi.nlm.nih.gov/pubmed/28644303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SPC.0000000000000278
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!